These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 19438502)
1. Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism? Karthikeyan G; Eikelboom JW; Turpie AG; Hirsh J Br J Haematol; 2009 Jul; 146(2):142-9. PubMed ID: 19438502 [TBL] [Abstract][Full Text] [Related]
2. Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism? Lowe G; Sandercock P Br J Haematol; 2010 Jan; 148(2):339-40. PubMed ID: 19807728 [No Abstract] [Full Text] [Related]
3. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients. Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080 [TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism in the medically ill patient: a call to action. Bergmann JF; Kher A Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352 [TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review. Duhl AJ J Reprod Med; 2008 Sep; 53(9):657-66. PubMed ID: 18839817 [TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism prophylaxis after major orthopaedic surgery: a pooled analysis of randomized controlled trials. Brown GA J Arthroplasty; 2009 Sep; 24(6 Suppl):77-83. PubMed ID: 19628366 [TBL] [Abstract][Full Text] [Related]
8. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring. Hull RD; Pineo GF; Stein P Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652 [TBL] [Abstract][Full Text] [Related]
10. Prevention of deep vein thrombosis in cancer patients. Lee AY Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798 [TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparins in cancer. Management and prevention of venous thromboembolism in patients with malignancies. ten Cate-Hoek AJ; Prins MH Thromb Res; 2008; 122(5):584-98. PubMed ID: 17996281 [TBL] [Abstract][Full Text] [Related]
12. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery. Colwell C; Mouret P Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914 [TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism prophylaxis for the general surgical patient: where do we stand? Petralia GA; Kakkar AK Semin Respir Crit Care Med; 2008 Feb; 29(1):83-9. PubMed ID: 18302090 [TBL] [Abstract][Full Text] [Related]
17. Thromboprophylaxis in orthopedic surgery: how long is long enough? Muntz J Am J Orthop (Belle Mead NJ); 2009 Aug; 38(8):394-401. PubMed ID: 19809604 [TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism prophylaxis for the medical patient: where do we stand? Yavin Y; Cohen AT Semin Respir Crit Care Med; 2008 Feb; 29(1):75-82. PubMed ID: 18302089 [TBL] [Abstract][Full Text] [Related]
19. Rivaroxaban for the prevention of venous thromboembolism following major orthopedic surgery: the RECORD trials. Ageno W Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):569-76. PubMed ID: 19505271 [TBL] [Abstract][Full Text] [Related]
20. Drug trials that have influenced our practice in the treatment of venous thromboembolism. Kearon C Thromb Haemost; 1997 Jul; 78(1):553-7. PubMed ID: 9198214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]